Carregant...
Increasing the safety and efficacy of chimeric antigen receptor T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a promising cancer treatment that has recently been undergoing rapid development. However, there are still some major challenges, including precise tumor targeting to avoid off-target or “on-target/off-tumor” toxicity, adequate T cell infiltration an...
Guardat en:
| Publicat a: | Protein Cell |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Higher Education Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5546931/ https://ncbi.nlm.nih.gov/pubmed/28434147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13238-017-0411-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|